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S U M M A R Y
Human recombinant interleukin-4 (rIL-4) was studied for its capacity to inhibit rIL-2-induced 
lymphoid cell aggregation. In contrast to rIL-2, rIL-4 was unable to induce cluster formation by 
itself. However, when added simultaneously with rIL-2 to cultures of freshly isolated peripheral 
blood lymphocytes (PBL), rIL-4 inhibited cell aggregation in a dose-dependent way. In contrast, 
PBL, preactivated by a 4-day culture in the presence of 500 U/ml rIL-2, were not inhibited in their 
adhesive capacity by rIL-4. Inhibition of cell aggregation was most prominent at 24 hr and virtually 
lost after 72 hr of culture. Phenotypical analysis revealed that rIL-4, with similar kinetics, decreased 
the rlL-2-mediated up-regulation of the CD2, CD54 and CD49e adhesion molecules. In addition, it 
was observed that up-regulation of the activation epitope on CD1 la recognized by the mAb NKI- 
L16, was prevented. During 24 hr of culture rIL-4 itself did not alter the expression of these antigens. 
Blocking experiments with mAb directed against adhesion structures did not reveal a direct role for 
CD49e, but obviously demonstrated involvement of CD1 la/CD18~CD54 and CD2-CD58 interac­
tions in the rIL-2-induced adhesion. Therefore, rIL-4 appears to inhibit the early phase of rIL-2- 
induced aggregation by preventing the up-regulation of CD54 and CD2  antigens and by inhibiting 
the generation of the activated state of the CD1 la/CD18 receptor.
INTRODUCTION
During recent years the importance of cell—cell contacts in the 
acti vation of an immune response has become increasingly clear 
(for review see ref. 1). Adhesion receptors form initial contacts 
between effector and target cells before cognate events occur.2,3 
Subsequently, upon antigen recognition a phase of ‘adhesion 
strengthening’ occurs, during which conformational changes in 
adhesion structures are thought to play a role.3"7 On lympho­
cytes activated states have been reported for the C D 1 1 a/CD  18 
ß2 integrin receptor, the altered conformation of which is 
recognized by the mAb NKI-L16,4,8 and for the CD49d, CD49e 
and CD49f molecules belonging to the V L A  ß\ subfamily of 
integrins.7 Upon stimulation of lymphoid cells with interleukin- 
2 (IL-2), a strong cluster formation is induced. However, only 
limited knowledge is available on the effect of IL-2 on the 
expression of adhesion associated structures. Preferentially on
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natural killer (NK) cells, rather than on T  lymphocytes, IL-2 
was found to increase the expression of the receptor/ligand pairs 
CDlla/CD18-CD54 and CD2-CD58.9 In another study IL-2- 
mediated increase in CD54 expression was detected on T  cells as 
well, particularly on those of the memory cell type.10 In 
preliminary experiments using human PBL, a diminished cluster 
formation was observed in cultures stimulated by recombinant 
(r)lL-2 in the presence of rIL-4. This observation bears 
resemblance to the reported inhibition by IL-4 of the IL-2- 
mediated proliferation and the generation of lymphokine- 
activated killer activity in cultures originating from resting 
T  cells or N K  cells.1114 In those studies the IL-4 inhibitory effect 
was not observed when IL-4 was added at least 24 hr after the 
start of the cultures. In addition, IL-4 itself did' not have any 
functional effect on resting T  cells or N K  cells, which is in line 
with the minimal expression of IL-4R on these cells.15 These 
data suggested that IL-4 inhibits an early IL-2-induced process. 
These observations prompted a detailed study on the effects of 
rIL-2 and rIL-4 on the expression of adhesion-associated 
structures during the process of cell aggregation, which precedes 
the induction of cellular proliferation. The results indicated that 
rIL-4 inhibits, early in culture, the expression of those adhesion 
molecules that are up-regulated by rIL-2, thereby delaying cell- 
cell contact. This may have direct consequences for the pro­
liferation capacity of the cells.
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MATERIALS AND M E TH O D S
Monoclonal antibodies (mAb) and cytokines 
The following mAb were used: SPV-T3b (anti-CD3, IgG2a),16 
CLB-FcRgranl (anti-CD16, IgG2a),17 CLB-IL2R/1 (anti- 
CD25, IgG2a),18 CLB-T11.1/1 (anti-CD2, IgGl),19 CLB-LFA- 
1/1 (anti-CD 18, IgGl),20 the latter four mAb kindly provided by 
Drs T. W .  J. Huizinga, R. A. W .  van Lier and F. Miedema from 
the Central Laboratory of the Netherlands Red Cross Blood 
Transfusion Service (Amsterdam, The Netherlands); p358 (anti- 
CD54, IgG2a),21 kindly provided by Dr J. P. Johnson (Institute 
for Immunology, Munich, Germany); F 10.3 (anti-CD54, 
IgGl),22 kindly provided by Dr A. Bloem (Academic Hospital, 
Utrecht, The Netherlands); NKI-L7 (anti-CDlla, IgGl),23 
NKI-L16 (anti-CDlla activation epitope, IgG2a),8 NKI-P1 
(anti-CD44, IgGl),24 TS2/9 (anti~CD58, IgGl)25 obtained 
through Dr T. A. Springer (Harvard Medical School, Boston, 
M A); H P  1/3 (anti-CD49d, IgGl)26 kindly provided by Dr F. 
Sanchez-Madrid (Hospital de la Princesa, Madrid, Spain); 
SAM-1 (anti-CD49e, IgG2b)27 and 4F2 (IgG2a) directed 
against the activation antigen 4F2.28
The cytokines used were Escherichia coli derived rIL-2 
(specific activity 3x  106 Cetus U/mg; Eurocetus, Amsterdam, 
The Netherlands) and rIL-4, obtained as purified protein from 
supernatants of L cells transfected with the c D N A  clone 
encoding IL-4 [kindly provided through Dr J. E. de Vries 
(specific activity 1*2 x 107 U/mg; D N A X ,  Palo Alto, CA ) by Dr 
S. Nagabhushan, Schering-Plough Corporation, Bloomfield, 
NY].
Cells and culture conditions
Peripheral blood lymphocytes (PBL) from normal donors were 
isolated by Ficoll-Hypaque density centrifugation, washed in 
Iscove’s medium (Flow Laboratories, Irvine, U .K.) supple­
mented with 5%  pooled, inactivated human serum (Central 
Laboratory of the Netherlands Red Cross Blood Transfusion 
Service), penicillin 100 IU/ml and kanamycin 100 ^g/ml (desig­
nated later as medium) and used either directly or after 
cryopreservation in 10% D M S O . As preactivated lymphocytes, 
PBL were used that were cultured for 4 days in the presence of 
rIL-2 500 U/ml. Small lymphocytes containing over 90%  T  cells 
and large lymphocytes (LL) enriched for up to 30% N K  cells 
were isolated from the peripheral blood from normal donors by 
centrifugal élutriation as described previously.29 Cell viability of 
all populations used was greater than 90 %  as detected by trypan 
blue dye exclusion. Cells at a concentration of 1 x 106/ml in a 
final volume of 1 ml were cultured at 37° in flat-bottomed 2-ml 
plates (Costar, Cambridge, M A )  either with or without different 
concentrations of rIL-2 and/or rIL-4 for the periods indicated.
Proliferation assay
The proliferation of the cells was determined by [3H]thymidine 
([3H]TdR) incorporation as described previously.30
Aggregation assay by microscopic examination 
The formation of cell aggregates was determined by at least two 
investigators using a light microscope as described previously,4 
Percentage aggregation was defined according to the formula:
Scores ranged from < 10% indicating almost no aggregates, to 
> 9 0 % , indicating cluster formation in large compact aggre­
gates. Standard deviation of scores was generally less than 10%.
To analyse reaggregation, the cells were washed in medium, 
vigorously resuspended and seeded in flat-bottomed 96-well 
microtitre plates (Costar) at 2 x 105/well in the presence or 
absence of rIL-2 100 U/ml or NKI-L16 m Ab (ascites dilution 
1:1000). Over a time period of 5 hr aggregation was scored as 
described above.
For blocking experiments small lymphocytes were cultured 
in the presence of rIL-2 (100 U/ml) and mAb (1/1000 ascites 
dilution) and scored for cell aggregation after 48-96 hr as 
described above. Due to limited availability of the C D 54  m Ab 
p358, in blocking experiments F10.3 m A b  was used.
Aggregation assay by FA C S  analysis
To analyse the early phase of aggregation, a FACS  cluster assay 
was used,31 as described previously.4 Briefly, cells (1 x 106/ml) 
were stained with the red dye hydroethidine (HE; Polyscience 
Inc., Warrington, PA ; 80 mg/ml in N,N-dimethylacetonide) at a 
concentration of 3 ng/ml or in another aliquot with the green 
dye sulphofluorescein diacetate (SFD A ; Molecular Probes, 
Junction City, O R ) at a concentration of 5 jug/ml. After 1 hr 
incubation at 37°, both cell aliquots were washed twice with 
medium and incubated for 30 min at 4°. Then 105 HE-labelled 
cells together with 105 SFDA-labelled cells were seeded in 
round-bottomed microtitre wells. NKI-L16 (ascites dilution 
1 :1000) was added to the wells and plates were directly spun for
2 min at 250 g [Hettich (Rotanta/RP) centrifuge]. Thereafter, 
cells were either fixed immediately with 0-5% paraformaldehyde 
(PFA) or upon subsequent culture at 37° for 5 min. The number 
of formed conjugates was determined using the FACScan 
(Becton Dickinson, Mountain View, CA). The percentage 
aggregation is quantitated by the percentage double fluorescent 
cells in quadrant 2, multiplied by a factor 2 to represent the 
percentage aggregation of a single fluorescent population.
Immunofluoi'escence assay
For surface marker analysis cells in PBS-BSA (0-5%; Sigma 
Chemical Co., St Louis, M O )  containing 0*01% w/v sodium 
azide, were incubated in the appropriate concentration of mAb 
for 30 min at 4°, followed by washing twice in PBS-BSA-azide 
and subsequent incubation in fluorescein isothiocyanate 
(FITC)-labelled goat (Fab ')2 anti-mouse IgG antibody (Nordic, 
Tilburg, The Netherlands) for 30 min at 4°. After washing in 
PBS-BSA-azide the percentage positive cells and the mean 
fluorescence intensity (MFI) were determined by FACScan 
analysis. Antigen density was expressed as the relative M F I  of 
cytokine-cultured cells compared to that of medium-cultured 
cells, the latter defined as 100%.
R E SU L T S
number of cells within clusters 
total number of cells
x 100%.
rIL-4 inhibits the rIL-2-induced cell aggregation of resting 
lymphocytes
To investigate the effect of rIL-2 and rIL-4 on cell aggregation, 
resting PBL  were incubated overnight in medium alone, in the 
presence of rIL-2 or rIL-4, or with a combination of both 
lymphokines. After 24 hr aggregation of lymphocytes was 
scored microscopically. As shown in Table I, rIL-2 strongly
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Table 1. Inhibition of rIL-2-induced cell aggregation by rIL-4
Culture in the presence of
Cell population* Medium rIL-4t rIL-2f rIL-2 +rIL-4
P B L  (« =  3) 8 +  8 Î 9 +  3 53 + 11 33 +  5
Small lymphocytes (n = 3) 6 ± 9 7 +  9 41 +  13 2 1 + 8
Large lymphocytes (/i =  4) 20 ±7 20 ± 7 62 ± 4 22  ± 8
Preactivated P B L  ( n ~  3) 83 +  6 85 +  5 85 +  5 87 ± 3
* P B L  were depleted from monocytes by I hr 37ô adherence to 
plastic; small and large lymphocytes were obtained by centrifugal 
élutriation; preactivated lymphocytes were obtained by culturing P B L  
for 4 days in the presence of rIL-2 500 U/ml prior to use. w =  number of 
experiments.
f rIL-2 used al 100 U/ml, rIL-4 at 100 U/ml.
I %  aggregation determined microscopically aL 24 hr; data are 
expressed as mean +  SE.
r IL -4  (U /m l)
Figure 1. Dose-dependent inhibition by rIL-4 of rIL-2-induced cell 
aggregation. L L  were incubated in 1000 U /m l rIL-2 in the presence of 
different doses of rIL-4 as indicated and scored for aggregation after 
24 hr. In the absence of rIL-2, with or without rIL-4» the level of 
aggregation did not exceed the 2 0 % .
induced the cells to form aggregates, whereas rIL-4 did not. 
However, when cells were cultured in the presence of both rIL-2 
and rIL-4, the percentage of cell aggregation was much lower 
compared to the effect of rIL-2 alone. The inhibitory effect of 
rIL-4 on cell aggregation was not observed with PB L  that were 
preactivated (Table 1). Inhibitory effects of rI.L-4 were obtained 
with cultures of both small and large lymphocytes, although the 
latter showed somewhat higher reactivity to rIL-2 (Table 1). 
Therefore, in most experiments described below L L  were used. 
The IL-4 inhibitory effect was observed with different rIL-2 
concentrations (100 U/ml and 1000 U/ml) and depended on the 
dose of rIL-4 used (Fig. 1). The reported inhibitory effect of 
rIL-4 on rIL-2 induced cellular proliferation12-14 was confirmed 
in this study and was found to correlate with the reduced cell 
aggregation (data not shown). These data indicate that resting 
lymphocytes can be induced to aggregate by culture in the 
presence of rIL-2, whereas rIL-4 inhibits this process.
rIL-4 does not affect the function of adhesion receptors
To investigate whether the inhibitory effect of rIL-4 was due to 
impairment of functional activity of adhesion receptors or to 
interference of IL-4 with the IL-2 signalling pathway leading to 
enhanced adhesion, reaggregation was studied using the mAb 
NKI-L16. Triggering of the LI 6 epitope of C D  1 la by this mAb 
has been found to be independent of intracellular signalling and 
is thought to induce a conformational change in the CDlla  
molecule resulting in the induction of firm aggregates within a 
few hours.4,5,8If rIL-4 interferes with IL-2 signalling and not with 
the activity of the adhesion receptors, cell aggregation would be 
expected to take place in the presence of NKI-L16 whether or 
not cells have been incubated in the presence of rIL-4. If rI.L-4 
affects the adhesion capacity of the receptors, cluster formation 
would be inhibited. LL  were cultured for 24 hr in the presence or 
absence of rIL-2 or rIL-4, thoroughly washed and resuspended 
in 3 aliquots containing either medium alone, or rIL-2 or the 
m Ab NKI-L16. During a period of 5 hr reaggregation was 
scored microscopically and the results are presented in Fig. 2. 
Cells cultured overnight in the presence of rIL-2 showed a rapid 
reaggregation. However, cells cultured overnight in medium 
alone did not aggregate unless NKI-L16 was added during the 
reaggregation period. Cells cultured overnight in the presence of 
rIL-4 behaved similarly to cells cultured overnight in medium 
alone. Although the kinetics of NKI-L16-induced reaggrega­
tion of rIL-4-precultured cells was somewhat slower than that of 
rIL-2-precultured cells, a comparable level of aggregation was 
obtained. This indicated that overnight culture in rIL-4 did not 
abolish the functional capacity of adhesion molecules but 
probably interfered with the signals induced by rIL-2 that result 
in the activation of adhesion receptors.
Kinetics of rïL-4-mediated inhibition of IL-2-induced cell 
aggregation
To investigate the effect of rIL-4 on the kinetics of cluster 
formation, L L  were incubated for a period of 72 hr in the 
presence of rIL-2, with or without rIL-4. At 24, 48 and 72 hr 
aliquots of cells were washed and resuspended in rIL-2 or NKI- 
L16 and reaggregation determined. The data depicted in Fig. 3 
demonstrated that the difference in reaggregation capacity 
between cells cultured in rIL-2 versus rIL-2 plus rIL-4 is most 
prominent at 24 hr (reaggregation in rIL-2 of 80 and 40% , 
respectively), declines at 48 hr and is lost at 72 hr. NKI-L16 
induced reaggregation is presented as a control to show that 
rIL-2 plus rIL-4-precultured cells are capable of reaggregating 
comparably to rIL-2-precultured cells. However, careful investi­
gation of clustering using F A C S  analysis instead of microscopic 
examination, indicated that the early kinetics of NKI-L16- 
induced reaggregation was more rapid for cells cultured over­
night in the presence of rIL-2 than for cells cultured overnight in 
the presence of rIL-2 plus rIL-4 (Fig. 4). In addition, cell 
aggregation in the culture wells themselves, also showed the 
same prominent reduction at 24 hr and loss of inhibition at 72 hr 
(data not shown). Thus the data indicate that rIL-4 interferes 
early during culture with rIL-2 signalling leading to cell-cell 
aggregation.
Effect of rIL-4 on the expression of adhesion molecules
To test whether the delay in optimal rIL-2-mediated cell 
aggregation produced by rIL-4 would correspond to altered
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Figure 2. Effect of overnight incubation in cytokines on the subsequent reaggregation capacity of L L . Cells were cultured overnight in 
medium (a), rlL-4 100 U/ml (b) or rIL-2 100 U/ml (c) washed and resuspended in medium (▼), rlL~2 100 U/ml ( • )  or NKI-L16 (ascites 
dilution 1:1000) (O). Reaggregation was scored for the time period indicated.
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Figure 3. Effect of preincubation in the presence of rIL-4 on the subsequent reaggregation capacity of L L . Cells were cultured for 24 (a), 
48 (b) or 72 hr (c) in the presence of rIL-2 100 U/ml in the absence ( • ,  o ) or presence (▼, v ) of rlL-4 100 U/ml. At each time-poinl cells 
were washed, resuspended in rIL-2 100 U/ml (0 , ▼) or NKI-L16 (1:1000) (O, v ) and scored for reaggregation capacity.
expression of adhesion structures on the surface of the cells, 
FACS analysis was carried out iii parallel with cell aggregation 
measurements. Cells from the experiment depicted in Fig. 3 were 
assayed at 24 and 72 hr for expression of adhesion molecules 
known to be involved in adhesion pathways between lymphoid 
cells, i.e. CDlla, CD18, CD54, CD2, CD58, CD49d, CD49e 
and CD44. As controls the CD25 IL-2R «-chain and the 
activation antigen 4F2 were measured, both known to be up- 
regulated by rIL-2. The results, representative for three experi­
ments, indicate that only small variations occurred in the 
percentage C D 3 + or C D 1 6 1 cells indicating that the composi­
tion of the cell population did not vary significantly between the 
different cytokine cultures (Table 2). Of all markers tested, only 
the percentage C D 2 5 + and C D 5 4 1 cells varied among the 
different cytokine cultures and these percentages were still 
reduced in rIL-4-supplemented cultures after 72 hr. On the other 
hand, as shown in Table 3, antigen density of certain adhesion 
receptors more closely, and with similar kinetics, correlated with 
the adhesion capacity of the cells in the different cytokine 
cultures. Early enhancement by rIL-2 (24 hr) of the expression 
of the L I6 epitope, CD54, CD2  and CD49e antigens was 
completely reduced to background levels in cultures supple­
mented with rIL-4. The rIL-2-enhanced expression of the 
activation markers C D 25  and 4F2 was only partially reduced by 
additional rIL-4. Incubation of cells in rIL-4 alone for 24 hr did 
not affect the expression of adhesion-associated molecules 
compared to cells cultured in medium alone. The rïL-4- 
mediated reduction in the rIL-2 up-regulated expression of L16 
epitope, CD54, C D 2  and CD49e observed at 24 hr, was virtually 
lost at 72 hr. Thus the expression profile of these antigens closely 
paralleled the observed differences in aggregation pattern of 
cells cultured in rIL-2 versus rIL-2 plus rIL-4 (compare Fig. 3). 
At 24 hr neither rIL-2 nor rIL-4 affected the expression of the 
adhesion molecules CD1 la, C D  18 or CD49d (Table 3). The up- 
regulation of the expression of these antigens observed at 72 hr, 
preferentially in rIL-2 and less in rIL~2 plus rIL-4-cultured cells, 
did not result in differences in lymphocyte aggregation pattern 
between these cultures.
Adhesion routes involved in rIL-2-induced cell aggregation
These data indicated that rIL-4 inhibited the early phase of 
rIL-2-induced cell adhesion and that this was correlated with
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Figure 4. F A C S  analysis of cluster formation upon reaggregation in the presence of NKI-L16. L L  cultured for 24 hr in medium (a), 
rIL-4 100 U /m l (b), rIL-2 100 U /m l (c) or rIL-2 +  rIL-4 (d) were processed as described in Materials and Methods. Clustered cells are 
shown as double fluorescent cells in quadrant 2 and are quantitated as percentage of single fluorescent cells as follows: medium (a) 7-8%, 
rIL-4 (b) 8 ’ 1 %> rIL-2 (c) 19-0% and rlL-2-b rIL-4 (d) 10*4%. Data are shown for cells fixed immediately after the start of reaggregation 
in the presence ofNKI-L16. Upon  incubation for an additional 5 min at 37° before fixation, cluster formation of cells cultured overnight 
in the presence of rIL-2 or rIL-2-f-rIL-4 raised to 30-0% and 19-2%, respectively (not shown).
early reduction in the expression of the adhesion molecules L16 
epitope, CD54, C D 2  and CD49e. To test whether these 
structures were essential for rIL-2-induced cluster formation, 
blocking experiments with the respective m A b  were performed. 
As shown in Table 4, m Ab directed to C D  11 a, C D  18, C D 54  and 
CD58, were capable of blocking rIL-2-induced cell aggregation. 
This confirmed the direct involvement of these adhesion 
receptors in rIL-2-induced lymphocyte aggregation. No inhibit­
ing effects were observed using m Ab  SAM-1 directed to CD49e. 
Additional experiments with two V L A  ß\ m Ab  (TS 2/16 and 
AIIB2) did not result in blocking of rIL-2-induced cell adhesion 
(data not shown). This suggested that the CD49e antigen does 
not play a primary role in rIL-2-induced cell aggregation.
D IS C U S S IO N
The results of the present study show that rIL-4 delayed the 
rIL-2-induced aggregation oflymphoid cells in a dose-depen­
dent way. The effect was observed when rIL-4 was added 
simultaneously with rIL-2 in cultures containing freshly isolated 
lymphocytes and not when preactivated cells were used. Dimin­
ished cell aggregation was most prominent at 24 hr of culture 
whereas it was lost at 72 hr. With similar kinetics rIL-4 
decreased the rIL-2-mediated enhancement of expression of the 
adhesion-associated surface markers L I 6 epitope of CDlla, 
CD2, C D 54  and CD49e. Recombinant IL-4 itself had no effect
on cell aggregation or adhesion marker expression early in 
culture. In addition, the reported inhibitory effect of rIL-4 on 
rIL-2-mediated proliferation12-14 was confirmed in our study 
and found to correlate with the effect of rIL-4 on cell aggrega­
tion (data not shown). Despite the fact that the down-regulating 
effect of rIL-4 on the adhesive capacity of the cells was not 
observed at 72 hr, the level of activation of the cells at 72 hr was 
still markedly reduced compared with rIL-2-cultured cells. 
Notably the reduced expression of the p55IL-2R (CD25), which 
together with the p75 IL-2R forms the high-affinity IL-2R,32“34 
may be responsible for the subsequent reduction in proliferative 
capacity of the cells.
Under conditions that rIL-4 inhibited rIL-2-induced cell 
aggregation, it also inhibited the rIL-2-induced cell prolifera­
tion. Notably, with both functional assays the effect was only 
observed with resting and not with preactivated lymphocytes. 
This suggested a causal relationship between both cellular 
functions. If this is the case, specific blocking of adhesion by 
m Ab to adhesion receptors is expected to result in blocking of 
subsequent proliferation. Experiments are in progress which 
indicate that CD1 la/CD18-CD54 interactions are indeed 
essential for rIL-2-induced proliferation (F. A. Vyth-Dreese, 
manuscript in preparation). Thus the rIL-4-mediated inhibition 
of lymphocyte aggregation early in culture may have direct 
consequences for the reduced proliferative capacity of IL-2- 
stimulated cells.
Table 2. Phenotypic analysis of L L  cultured in the presence of rIL-2 and/or rIL-4
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Antigen m A b
Time of 
culture (hr)
Culture in the presence of
Medium rIL-4 riL-2 rIL-2 +  rIL-4
C D 3 SPV-T3b 0 74*
24 78 77 79 77
72 76 75 75 73
C D 1 6 CLB-FcRgran 1 0 31
24 27 26 30 29
72 2 2 21 27 28
C D 25 CLB-IL-2R/1 0 33
24 48 46 58 40
72 36 37 63 39
C D 5 4 p358 0 10
24 13 13 51 29
72 15 15 73 52
C D 1  la NKI-L16
L I 6 epitope •
C D l l a NKI-L7
C D 18 CLB-LFA-I/1 A 1
C D 2 CLB-T1L1/1
0
C D 58 TS2/9
24 }
r*jr\ 1
>90 > 9 0 > 9 0 > 90
C D 49d H P  1/3
72 J
CD49e SAM-1
C D 4 4 N KI- P1
4F2 4F2
i
* %  positive cells.
Table 3. Regulation of surface marker expression by rIL-2 and/or rIL~4
Relative M F I
24 hr 72 hr
Antigen rIL-4 rIL-2 rIL-2+rIL-4 rIL-4 rIL-2 rIL-2 rl L-4
CDlla-L16 epitope 99* 140 103 114 130 121
C D lla 110 106 112 109 157 138
C D 18 93 95 93 94 161 105
C D 5 4 100 890 110 89 833 733
C D 2 93 132 108 187 389 335
C D 58 96 120 105 79 124 94
CD49d 99 118 108 96 151 118
CD49e 101 148 n o 66 93 66
C D 4 4 107 91 85 130 78 76
C D 25 110 335 180 128 648 367
4F2 102 173 129 81 213 190
C D 3 98 111 101 80 101 96
* %  of M F I  of medium-cultured cells.
The ratio for M F I  values of m A b  versus background (negative control) for the above listed 
antigens varied from 7 to 200 in freshly obtained L L , from 9 to 230 for 24 hr and from 11 to 280 
for 72 hr cultured cells. The exception is the anti-CD54 m A b  that did not stain the fresh and 
medium-cultured cells above backgroxind level,
Whereas previous studies have shown that the IL-4 inhibi­
tory effect on cell proliferation and the generation of lympho- 
kine-activated killer activity is an early effect taking place in the 
first 24 hr of culture,1114 our data demonstrate that the rIL-4 
effect on cell aggregation is transient, being visible only in the
first 24-48 hr. In view of the shared homology of the extra­
cellular domains of the p75 IL-2R and the IL-4R,35 it is tempting 
to speculate that hindering by rIL-4 of the interaction between 
rIL-2 and the p75 IL-2R would play a role. The transient 
character of the inhibition by rIL-4 may be explained by the fact
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Table 4. Adhesion structures involved in IL-2-induced cell aggregation
Culture in presence ofrIL-2 
supplemented with m A b Antigen Aggregation range (% )
U 30-60 (6/6 )*
NKI-L16 C D l l a  
L I 6  epitope
> 60 (6/6 )
NKI-L15 C D l l a < 10-30 (5/6)
CLB-LFA-I /1 C D  18 < 10(5 /6 )
F 10,3 C D  54 10-30(3/4)
TS2/9 C D 5 8 10-30(3/5)
H P  1/3 C D 4 9 d > 6 0  (5/5)
SAM-I C D 49e 30-60 (3/4)
4F2 4F2 30-60 (5/5)
Small lymphocytes were cultured in the presence of rIL-2 ( 100 U/ml) 
and adhesion-associated m A b  (1/1000) and scored for cell aggregation 
after 48-96 hr of culture, In the absence of rIL-2, only NKI-L16 and 
H P  1/3 induced cell aggregation above background level (which was 
< 10%).
* No. of experiments in which aggregation was scored within the 
range shown/total no. of experiments. In the other experiments m A b  did 
change aggregation.
that inhibition of CD25  expression at 24 hr is not complete (see 
Table 3). Even in the presence of rIL-4, IL-2 may continue to 
bind to p75 and p55 subunits, thereby up-regulating p55 further 
to a level sufficient to activate the cells to form clusters.
The inhibitory effect of rIL~4 on rIL-2-induced lymphocyte 
aggregation was found to correlate with a reduced expression of 
the adhesion molecules L I 6 epitope, CD54, C D 2  and CD49e. 
The data from Table 4 confirm that CD1 la/CD18-CD54 and 
CD2-CD58 interactions are directly involved in rIL-2 induced 
adhesion. Thus it can be concluded that iTL-4 inhibits rIL-2- 
induced cell aggregation by preventing the early up-regulation 
of the C D 2  and CD54 receptors. In the case of the C D  11 a /CD  18 
antigen, rIL-4 appears to inhibit the generation of the activated 
state of the receptor as shown by the reduced expression of the 
L I 6 epitope. On the other hand, the m Ab used to detect the 
CD49e antigen, SAM-1, did not block rIL-2-induced aggrega­
tion (Table 4), nor did two CD29  (V L A  ßl) m A b  (data not 
shown). Therefore, it is unlikely that the CD49e antigen is 
directly involved in rIL-2-induced adhesion. In agreement with 
previous observations of Campanero et al.?6 the CD49d mAb 
H P  1/3 was found to stimulate aggregation (Table 4). This effect 
was related to the activation state of the cells since it was 
observed more profoundly upon prolonged incubation in the 
presence of rIL-2 (data not shown). Recombinant IL-2, in turn, 
was found to up-regulate CD49d  expression, but only after 
several days of culture (see Table 3). Therefore, the CD49d 
molecule seemed to play a secondary role in facilitating cell-cell 
interaction after the onset of IL-2-induced adhesion had taken 
place. And even during the later stages of IL-2-induced cell 
aggregation, differences in CD49d  expression seemed to have 
less impact on the adhesion capacity of the cells compared with 
that of LI 6 epitope, C D 2  and C D 54  adhesion receptors. 
Therefore it is concluded that the latter molecules are the main 
determinants of IL-2~induced cell adhesion.
In the cascade of events that take place when an antigen- 
specific T  lymphocyte encounters its target cell, non-specific 
contact is thought to precede cognate events.2 Upon subsequent 
T-cell triggering, adhesion structures become activated,3^ 7 ad' 
hesion strengthening occurs and firm effector/target interaction 
results in optimal effector function.3 This pathway may be 
mimicked by stimulation with IL-2 (ref. 5 and the present 
study). Thus the physiological role of IL-4 would be to prevent 
the phase of initial, non-specific cell-cell contact, and sub' 
sequent progression to the phase of adhesion strengthening in 
the absence of antigen. In the presence of antigen, or by 
perturbation of adhesion molecules artificially by mAb trigger­
ing, the activated state of the adhesion structures would be 
favoured and the effect of IL-4 would be counteracted, Indeed, 
incubation of lymphocytes in the presence of NKI-L16, known 
to induce the activation state of the CD1 la molecule,3“5,8 was 
found to abrogate the effect orrIL-4 in rIL-2-slimulated cultures 
supplemented with rIL-4 (see Fig. 3).
Thus, it is concluded that rIL-4 inhibits the early phase of 
rIL-2-mediated cell aggregation by reducing the expression of 
those molecules that are important for initial non-specific cell- 
cell contact. These structures determine the subsequent phase of 
adhesion strengthening in the presence of antigen. The latter 
process is mimicked by NKI-L16 induced reaggregation and 
under these conditions the negative effect of rIL-4 is overruled. 
These data confirm the importance of IL-2 and IL-4 as 
regulatory molecules for lymphoid cell activation and differen­
tiation, and stress the essential role of cell-cell interactions in 
these processes.
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